Burosumab for treating X-linked hypophosphataemia in children and young people

Highly specialised technologies guidance
Reference number: HST8
Published: 10 October 2018
Last updated: 08 April 2025

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 239 KB)

Published:

10 October 2018

Final evaluation determination

Final evaluation determination
Final evaluation determination document (PDF 390 KB)

Published:

05 September 2018
Public committee slides (PDF 1.43 MB)

Published:

05 September 2018
Committee papers (PDF 4.6 MB)

Published:

05 September 2018

Evaluation consultation

Evaluation consultation
Public committee slides (PDF 1.02 MB)

Published:

15 June 2018
Committee papers (PDF 27 MB)

Published:

15 June 2018
Evaluation consultation document (PDF 408 KB)

Published:

15 June 2018

Invitation to participate

Final scope (PDF 221 KB)

Published:

05 December 2017
NICE's response to comments on the draft scope and provisional matrix (PDF 447 KB)

Published:

05 December 2017
Equality Impact Assessment (Guidance development) (PDF 174 KB)

Published:

05 December 2017
Final matrix (PDF 333 KB)

Published:

06 December 2017